. 2018 Jul 16;8(7):e021346. doi: 10.1136/bmjopen-2017-021346

Table 3.

Schedule of study protocol periods and assessments

Activity/assessment	Study periods and visits
	Recruitment	Preintervention	Intervention						Follow-up
		V0	V1	V2	V3	V4	V5	V6	V7
Eligibility screen	X
Informed consent	X
Delivery and training of devices	X
Sociodemographic data		X
Clinical characteristics		X
Relapse signature and treatment plan		X
Willingness to enrol	X
Attrition		X	X	X	X	X	X	X	X
TAM²⁷									X
User Experience Questionnaire			X		X		X		X
Interval Question			X	X	X	X	X	X	X
CSQ-8²⁸									X
PANSS²⁹		X							X
CDS³⁰		X							X
SUMD³²		X							X
ARMS³³		X							X
CGI-SCH³¹		X	X	X	X	X	X	X	X
GAF³⁴		X							X
SFS³⁵		X							X
EQ-5D³⁶		X							X
Economic and organisational outcomes		X							X
Safety measures		X	X	X	X	X	X	X	X

ARMS, Adherence to Refills and Medications Scale; CDS, Calgary Depression Scale; CGI-SCH, Clinical Global Impression-Schizophrenia; CSQ-8, Client Satisfaction Questionnaire 8; EQ-5D, EuroQol 5 dimensions; GAF, Global Assessment of Functioning; PANSS, Positive and Negative Syndrome Scale; SFS, Social Functioning Scale; SUMD, Scale Unawareness Mental Disorders; TAM, Technology Acceptance Model scale.